Tenvie Therapeutics Emerges to Revolutionize Treatment of Neurological Diseases

Tenvie Therapeutics has launched with a focus on transforming the treatment of neurological diseases. The company's substantial $200 million funding round is set to propel its growth as it capitalizes on its extensive portfolio of small molecule assets and experienced research and development team.